Galapagos receives transparency notification and 13D filing from Tang Capital
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification…
24,840€
-0,32%
Echtzeit-Aktienkurs GALAPAGOS N.V.
Bid:
Ask:
Nachrichten zur GALAPAGOS N.V. Aktie
Galapagos downgraded by Barclays, PT cut to €22 By Investing.com
Galapagos downgraded by Barclays, PT cut to €22…
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Mechelen, Belgium; December 7, 2024, 18:30 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced additional data from the ongoing…
Galapagos NV 2024 Q3 - Results - Earnings Call Presentation
…
Galapagos NV (GLPG) Q3 2024 Earnings Call Transcript
…
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma
Mechelen, Belgium; August 23, 2024, 07:00 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today…
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging…
Galapagos NV (GLPG) Q1 2024 Earnings Call Transcript
…